source
- Skye Bioscience and Redx Pharma combine to form Fibrx Therapeutics with $125M financing for fibrosis pipelineSkye Bioscience announced a combination with privately held Redx Pharma, creating a new public company called Fibrx Therapeutics. The transaction is structured as a reverse merger and provides $12…
- After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?Two recent patient deaths—both involving severe immune reactions to high-dose, viral vector-delivered gene therapies and a lack of disclosures—have drawn international scrutiny to what appear to be…Fierce Biotech · 3d ago↗ source